FIELD: medicine.
SUBSTANCE: invention refers to medicine and aims at treating degenerative processes of the musculoskeletal system. Composition contains glucosamine sulphate sodium chloride and dalargin as active substances and sodium disulphite, citric acid, phenol, lidocaine hydrochloride, trometamol as auxiliary substances, with the following content of components, mg: glucosamine sulphate sodium chloride: 200–300 mg; dalargin: 0.5–1.5 mg; lidocaine hydrochloride: 2.0–15 mg; sodium disulphite: 0.5–5.0 mg; citric acid: 0.1–1.0 mg; phenol: 0.5–3.0 mg; trometamol: up to pH 2.0–3.0; water for injections: up to 1 ml.
EFFECT: invention provides improved pharmacological action, reduced side effects and maintained stability during the whole storage life of the preparation.
1 cl, 3 ex
